{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T09:45:23Z","timestamp":1782726323435,"version":"3.54.5"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Biomed. Eng"],"DOI":"10.1038\/s41551-026-01697-5","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T09:03:50Z","timestamp":1782723830000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Off\u2011the\u2011shelf, engineered non-living stem cell strategy for advancing cellular therapies"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0377-1153","authenticated-orcid":false,"given":"Tiep Tien","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2424-8758","authenticated-orcid":false,"given":"Nhu-Nam","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8242-4290","authenticated-orcid":false,"given":"Linh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim-Phuong","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5653-8619","authenticated-orcid":false,"given":"Junhyeung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Hyuk","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simmyung","family":"Yook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu-Lin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7120-169X","authenticated-orcid":false,"given":"Jee-Heon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"1697_CR1","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41573-022-00476-6","volume":"21","author":"CJ Bashor","year":"2022","unstructured":"Bashor, C. J., Hilton, I. B., Bandukwala, H., Smith, D. M. & Veiseh, O. Engineering the next generation of cell-based therapeutics. Nat. Rev. Drug Discov. 21, 655\u2013675 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1697_CR2","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/s44222-023-00148-z","volume":"2","author":"N Eckman","year":"2024","unstructured":"Eckman, N., Nejatfard, A., Cavet, R., Grosskopf, A. K. & Appel, E. A. Biomaterials to enhance adoptive cell therapy. Nat. Rev. Bioeng. 2, 408\u2013424 (2024).","journal-title":"Nat. Rev. Bioeng."},{"key":"1697_CR3","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/s44222-024-00219-9","volume":"2","author":"A Hotta","year":"2024","unstructured":"Hotta, A., Schrepfer, S. & Nagy, A. Genetically engineered hypoimmunogenic cell therapy. Nat. Rev. Bioeng. 2, 960\u2013979 (2024).","journal-title":"Nat. Rev. Bioeng."},{"key":"1697_CR4","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.stem.2025.03.004","volume":"32","author":"T Deuse","year":"2025","unstructured":"Deuse, T. & Schrepfer, S. Progress and challenges in developing allogeneic cell therapies. Cell Stem Cell 32, 513\u2013528 (2025).","journal-title":"Cell Stem Cell"},{"key":"1697_CR5","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.stem.2025.05.008","volume":"32","author":"S Viswanathan","year":"2025","unstructured":"Viswanathan, S. & Galipeau, J. Hallmarks of MSCs: key quality attributes for pharmacology and clinical use. Cell Stem Cell 32, 878\u2013894 (2025).","journal-title":"Cell Stem Cell"},{"key":"1697_CR6","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41392-024-01809-0","volume":"9","author":"J Cerneckis","year":"2024","unstructured":"Cerneckis, J., Cai, H. & Shi, Y. Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications. Signal Transduct. Target. Ther. 9, 112 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1697_CR7","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41551-022-00987-y","volume":"7","author":"S Skidmore","year":"2023","unstructured":"Skidmore, S. & Barker, R. A. Challenges in the clinical advancement of cell therapies for Parkinson\u2019s disease. Nat. Biomed. Eng. 7, 370\u2013386 (2023).","journal-title":"Nat. Biomed. Eng."},{"key":"1697_CR8","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1038\/s41591-024-03281-3","volume":"30","author":"SP Svendsen","year":"2024","unstructured":"Svendsen, S. P. & Svendsen, C. N. Cell therapy for neurological disorders. Nat. Med. 30, 2756\u20132770 (2024).","journal-title":"Nat. Med."},{"key":"1697_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba6884","volume":"6","author":"O Levy","year":"2020","unstructured":"Levy, O. et al. Shattering barriers toward clinically meaningful MSC therapies. Sci. Adv. 6, eaba6884 (2020).","journal-title":"Sci. Adv."},{"key":"1697_CR10","doi-asserted-by":"publisher","first-page":"eaat2189","DOI":"10.1126\/scitranslmed.aat2189","volume":"11","author":"I Martin","year":"2019","unstructured":"Martin, I., Galipeau, J., Kessler, C., Le Blanc, K. & Dazzi, F. Challenges for mesenchymal stromal cell therapies. Sci. Transl. Med. 11, eaat2189 (2019).","journal-title":"Sci. Transl. Med."},{"key":"1697_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13287-019-1224-y","volume":"10","author":"N Noronha C\u00e1ssia de","year":"2019","unstructured":"Noronha C\u00e1ssia de, N. et al. Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies. Stem Cell Res. Ther. 10, 131 (2019).","journal-title":"Stem Cell Res. Ther."},{"key":"1697_CR12","doi-asserted-by":"publisher","first-page":"20190815","DOI":"10.1098\/rsif.2019.0815","volume":"17","author":"DT Boyt","year":"2020","unstructured":"Boyt, D. T., Boland, L. K., Burand, A. J., Brown, A. J. & Ankrum, J. A. Dose and duration of interferon \u03b3 pre-licensing interact with donor characteristics to influence the expression and function of indoleamine-2,3-dioxygenase in mesenchymal stromal cells. J. R. Soc. Interface 17, 20190815 (2020).","journal-title":"J. R. Soc. Interface"},{"key":"1697_CR13","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41392-024-01936-8","volume":"9","author":"Y Shan","year":"2024","unstructured":"Shan, Y. et al. Pharmacokinetic characteristics of mesenchymal stem cells in translational challenges. Signal Transduct. Target. Ther. 9, 242 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1697_CR14","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","volume":"16","author":"IK Herrmann","year":"2021","unstructured":"Herrmann, I. K., Wood, M. J. A. & Fuhrmann, G. Extracellular vesicles as a next-generation drug delivery platform. Nat. Nanotechnol. 16, 748\u2013759 (2021).","journal-title":"Nat. Nanotechnol."},{"key":"1697_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s44222-024-00255-5","volume":"3","author":"M Manno","year":"2025","unstructured":"Manno, M., Bongiovanni, A., Margolis, L., Bergese, P. & Arosio, P. The physico-chemical landscape of extracellular vesicles. Nat. Rev. Bioeng. 3, 68\u201382 (2025).","journal-title":"Nat. Rev. Bioeng."},{"key":"1697_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41392-022-00947-7","volume":"7","author":"Z Fu","year":"2022","unstructured":"Fu, Z., Li, S., Han, S., Shi, C. & Zhang, Y. Antibody drug conjugate: the \u2018biological missile\u2019 for targeted cancer therapy. Signal Transduct. Target. Ther. 7, 93 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1697_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38039-x","volume":"14","author":"SB Ebrahimi","year":"2023","unstructured":"Ebrahimi, S. B. & Samanta, D. Engineering protein-based therapeutics through structural and chemical design. Nat. Commun. 14, 2411 (2023).","journal-title":"Nat. Commun."},{"key":"1697_CR18","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41392-025-02312-w","volume":"10","author":"G Xu","year":"2025","unstructured":"Xu, G. et al. Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies. Signal Transduct. Target. Ther. 10, 255 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1697_CR19","doi-asserted-by":"publisher","first-page":"eaat9683","DOI":"10.1126\/scitranslmed.aat9683","volume":"12","author":"K Huang","year":"2020","unstructured":"Huang, K. et al. An off-the-shelf artificial cardiac patch improves cardiac repair after myocardial infarction in rats and pigs. Sci. Transl. Med. 12, eaat9683 (2020).","journal-title":"Sci. Transl. Med."},{"key":"1697_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13724","volume":"8","author":"J Tang","year":"2017","unstructured":"Tang, J. et al. Therapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome. Nat. Commun. 8, 13724 (2017).","journal-title":"Nat. Commun."},{"key":"1697_CR21","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1161\/CIRCRESAHA.116.310374","volume":"120","author":"L Luo","year":"2017","unstructured":"Luo, L. et al. Fabrication of synthetic mesenchymal stem cells for the treatment of acute myocardial infarction in mice. Circ. Res. 120, 1768\u20131775 (2017).","journal-title":"Circ. Res."},{"key":"1697_CR22","doi-asserted-by":"crossref","unstructured":"Bao, H. et al. Exosome-loaded degradable polymeric microcapsules for the treatment of vitreoretinal diseases. Nat. Biomed. Eng. 8, 1436\u20131452 (2024).","DOI":"10.1038\/s41551-023-01112-3"},{"key":"1697_CR23","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41551-021-00729-6","volume":"5","author":"ZW Wagoner","year":"2021","unstructured":"Wagoner, Z. W. & Zhao, W. Therapeutic implications of transplanted-cell death. Nat. Biomed. Eng. 5, 379\u2013384 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"1697_CR24","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41423-023-01018-9","volume":"20","author":"C Giacomini","year":"2023","unstructured":"Giacomini, C., Gran\u00e9li, C., Hicks, R. & Dazzi, F. The critical role of apoptosis in mesenchymal stromal cell therapeutics and implications in homeostasis and normal tissue repair. Cell. Mol. Immunol. 20, 570\u2013582 (2023).","journal-title":"Cell. Mol. Immunol."},{"key":"1697_CR25","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/d41573-022-00097-z","volume":"21","author":"S Crunkhorn","year":"2022","unstructured":"Crunkhorn, S. Promoting efferocytosis heals diabetic wounds. Nat. Rev. Drug Discov. 21, 491 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1697_CR26","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41586-022-04754-6","volume":"606","author":"S Maschalidi","year":"2022","unstructured":"Maschalidi, S. et al. Targeting SLC7A11 improves efferocytosis by dendritic cells and wound healing in diabetes. Nature 606, 776\u2013784 (2022).","journal-title":"Nature"},{"key":"1697_CR27","doi-asserted-by":"publisher","first-page":"122319","DOI":"10.1016\/j.biomaterials.2023.122319","volume":"302","author":"M Chen","year":"2023","unstructured":"Chen, M. et al. Potentiating cancer vaccination by adjuvant-loaded cryo-shocked tumor cells. Biomaterials 302, 122319 (2023).","journal-title":"Biomaterials"},{"key":"1697_CR28","doi-asserted-by":"publisher","first-page":"eabc3013","DOI":"10.1126\/sciadv.abc3013","volume":"6","author":"T Ci","year":"2020","unstructured":"Ci, T. et al. Cryo-shocked cancer cells for targeted drug delivery and vaccination. Sci. Adv. 6, eabc3013 (2020).","journal-title":"Sci. Adv."},{"key":"1697_CR29","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41392-023-01703-1","volume":"9","author":"L Wu","year":"2024","unstructured":"Wu, L. et al. Camouflaging attenuated Salmonella by cryo-shocked macrophages for tumor-targeted therapy. Signal Transduct. Target. Ther. 9, 14 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1697_CR30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41551-021-00795-w","volume":"6","author":"J Guo","year":"2022","unstructured":"Guo, J. et al. Cancer vaccines from cryogenically silicified tumour cells functionalized with pathogen-associated molecular patterns. Nat. Biomed. Eng. 6, 19\u201331 (2022).","journal-title":"Nat. Biomed. Eng."},{"key":"1697_CR31","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41392-021-00688-z","volume":"6","author":"X He","year":"2021","unstructured":"He, X. et al. Spontaneous apoptosis of cells in therapeutic stem cell preparation exert immunomodulatory effects through release of phosphatidylserine. Signal Transduct. Target. Ther. 6, 270 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1697_CR32","doi-asserted-by":"publisher","first-page":"718191","DOI":"10.3389\/fimmu.2021.718191","volume":"12","author":"PV van Heerden","year":"2021","unstructured":"van Heerden, P. V. et al. Apoptotic cells for therapeutic use in cytokine storm associated with sepsis\u2014a phase Ib clinical trial. Front. Immunol. 12, 718191 (2021).","journal-title":"Front. Immunol."},{"key":"1697_CR33","doi-asserted-by":"publisher","first-page":"eadk8264","DOI":"10.1126\/sciadv.adk8264","volume":"10","author":"F Liu","year":"2024","unstructured":"Liu, F. et al. Cryo-shocked tumor cells deliver CRISPR\u2013Cas9 for lung cancer regression by synthetic lethality. Sci. Adv. 10, eadk8264 (2024).","journal-title":"Sci. Adv."},{"key":"1697_CR34","doi-asserted-by":"publisher","first-page":"134146","DOI":"10.1016\/j.cej.2021.134146","volume":"432","author":"A Bigham","year":"2022","unstructured":"Bigham, A. et al. Advances in tannic acid-incorporated biomaterials: infection treatment, regenerative medicine, cancer therapy, and biosensing. Chem. Eng. J. 432, 134146 (2022).","journal-title":"Chem. Eng. J."},{"key":"1697_CR35","doi-asserted-by":"publisher","first-page":"2100347","DOI":"10.1002\/adhm.202100347","volume":"10","author":"H Lee","year":"2021","unstructured":"Lee, H. et al. A decade of advances in single-cell nanocoating for mammalian cells. Adv. Healthc. Mater. 10, 2100347 (2021).","journal-title":"Adv. Healthc. Mater."},{"key":"1697_CR36","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ajt.2023.01.007","volume":"23","author":"JM Barra","year":"2023","unstructured":"Barra, J. M. et al. Localized cytotoxic T cell-associated antigen 4 and antioxidant islet encapsulation alters macrophage signaling and induces regulatory and anergic T cells to enhance allograft survival. Am. J. Transplant. 23, 498\u2013511 (2023).","journal-title":"Am. J. Transplant."},{"key":"1697_CR37","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1089\/scd.2016.0068","volume":"25","author":"F Luk","year":"2016","unstructured":"Luk, F. et al. Inactivated mesenchymal stem cells maintain immunomodulatory capacity. Stem Cells Dev. 25, 1342\u20131354 (2016).","journal-title":"Stem Cells Dev."},{"key":"1697_CR38","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13287-020-02087-7","volume":"12","author":"J-Y Lim","year":"2021","unstructured":"Lim, J.-Y. et al. The therapeutic efficacy of mesenchymal stromal cells on experimental colitis was improved by the IFN-\u03b3 and poly(I:C) priming through promoting the expression of indoleamine 2,3-dioxygenase. Stem Cell Res. Ther. 12, 37 (2021).","journal-title":"Stem Cell Res. Ther."},{"key":"1697_CR39","doi-asserted-by":"publisher","first-page":"119403","DOI":"10.1016\/j.biomaterials.2019.119403","volume":"220","author":"JR Garc\u00eda","year":"2019","unstructured":"Garc\u00eda, J. R. et al. IFN-\u03b3-tethered hydrogels enhance mesenchymal stem cell-based immunomodulation and promote tissue repair. Biomaterials 220, 119403 (2019).","journal-title":"Biomaterials"},{"key":"1697_CR40","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41575-024-01035-7","volume":"22","author":"S Vieujean","year":"2025","unstructured":"Vieujean, S. et al. Understanding the therapeutic toolkit for inflammatory bowel disease. Nat. Rev. Gastroenterol. Hepatol. 22, 371\u2013394 (2025).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1697_CR41","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.1172\/JCI124884","volume":"129","author":"V Langer","year":"2019","unstructured":"Langer, V. et al. IFN-\u03b3 drives inflammatory bowel disease pathogenesis through VE-cadherin-directed vascular barrier disruption. J. Clin. Invest. 129, 4691\u20134707 (2019).","journal-title":"J. Clin. Invest."},{"key":"1697_CR42","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/stmcls\/sxac075","volume":"41","author":"HY Park","year":"2023","unstructured":"Park, H. Y. et al. Priming mesenchymal stem\/stromal cells with a combination of a low dose of IFN-\u03b3 and bortezomib results in potent suppression of pathogenic Th17 immunity through the IDO1\u2013AHR axis. Stem Cells 41, 64\u201376 (2023).","journal-title":"Stem Cells"},{"key":"1697_CR43","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41419-020-02788-0","volume":"11","author":"R Yang","year":"2020","unstructured":"Yang, R. et al. IFN-\u03b3 promoted exosomes from mesenchymal stem cells to attenuate colitis via miR-125a and miR-125b. Cell Death Dis. 11, 603 (2020).","journal-title":"Cell Death Dis."},{"key":"1697_CR44","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.3390\/biomedicines12081764","volume":"12","author":"D Wang","year":"2024","unstructured":"Wang, D., Chen, W., Cao, J., Si, L. & Chen, Z. Establishment and evaluation of a mouse model of experimental ulcerative colitis induced by the gavage administration of dextran sulfate sodium. Biomedicines 12, 1764 (2024).","journal-title":"Biomedicines"},{"key":"1697_CR45","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41536-019-0083-6","volume":"4","author":"MF Pittenger","year":"2019","unstructured":"Pittenger, M. F. et al. Mesenchymal stem cell perspective: cell biology to clinical progress. npj Regen. Med. 4, 22 (2019).","journal-title":"npj Regen. Med."},{"key":"1697_CR46","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-022-00932-0","volume":"7","author":"Y Han","year":"2022","unstructured":"Han, Y. et al. The secretion profile of mesenchymal stem cells and potential applications in treating human diseases. Sig. Transduct. Target. Ther. 7, 92 (2022).","journal-title":"Sig. Transduct. Target. Ther."},{"key":"1697_CR47","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41392-022-01134-4","volume":"7","author":"DM Hoang","year":"2022","unstructured":"Hoang, D. M. et al. Stem cell-based therapy for human diseases. Sig. Transduct. Target Ther. 7, 272 (2022).","journal-title":"Sig. Transduct. Target Ther."},{"key":"1697_CR48","doi-asserted-by":"publisher","first-page":"13511","DOI":"10.1073\/pnas.1411295111","volume":"111","author":"Y Li","year":"2014","unstructured":"Li, Y. et al. Primed 3D injectable microniches enabling low-dosage cell therapy for critical limb ischemia. Proc. Natl Acad. Sci. USA 111, 13511\u201313516 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1697_CR49","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.7150\/thno.74785","volume":"12","author":"J Han","year":"2022","unstructured":"Han, J., Luo, L., Marcelina, O., Kasim, V. & Wu, S. Therapeutic angiogenesis-based strategy for peripheral artery disease. Theranostics 12, 5015\u20135033 (2022).","journal-title":"Theranostics"},{"key":"1697_CR50","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.clinthera.2023.09.005","volume":"45","author":"J Golledge","year":"2023","unstructured":"Golledge, J. Pathology, progression, and emerging treatments of peripheral artery disease\u2013related limb ischemia. Clin. Ther. 45, 1077\u20131086 (2023).","journal-title":"Clin. Ther."},{"key":"1697_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2025.103783","volume":"6","author":"S Sharma","year":"2025","unstructured":"Sharma, S. et al. Protocol for modeling blood flow recovery and angiogenesis in response to hindlimb ischemia. STAR Protoc. 6, 103783 (2025).","journal-title":"STAR Protoc."},{"key":"1697_CR52","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1113\/EP091901","volume":"109","author":"WS Evans","year":"2024","unstructured":"Evans, W. S., Pena, G. S., Gelman, B., Kuzmiak-Glancy, S. & Prior, S. J. Unilateral hindlimb ischaemia-induced systemic inflammation is associated with non-ischaemic skeletal muscle inflammation. Exp. Physiol. 109, 1604\u20131613 (2024).","journal-title":"Exp. Physiol."},{"key":"1697_CR53","doi-asserted-by":"publisher","first-page":"271","DOI":"10.4155\/fmc-2021-0081","volume":"14","author":"DS Dhanjal","year":"2022","unstructured":"Dhanjal, D. S. et al. Concepts of advanced therapeutic delivery systems for the management of remodeling and inflammation in airway diseases. Future Med. Chem. 14, 271\u2013288 (2022).","journal-title":"Future Med. Chem."},{"key":"1697_CR54","unstructured":"Ita, K. in Drug Delivery 43\u201370 (Academic Press, 2025)."},{"key":"1697_CR55","first-page":"262","volume":"33","author":"WT Lee","year":"2024","unstructured":"Lee, W. T. et al. Alveolar macrophage phagocytosis-evading inhaled microgels incorporating nintedanib-PLGA nanoparticles and pirfenidone-liposomes for improved treatment of pulmonary fibrosis. Bioact. Mater 33, 262\u2013278 (2024).","journal-title":"Bioact. Mater"},{"key":"1697_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.pscia.2023.100031","volume":"2","author":"ZH Mok","year":"2024","unstructured":"Mok, Z. H. The effect of particle size on drug bioavailability in various parts of the body. Pharm. Sci. Adv. 2, 100031 (2024).","journal-title":"Pharm. Sci. Adv."},{"key":"1697_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actbio.2022.11.003","volume":"155","author":"D Salthouse","year":"2023","unstructured":"Salthouse, D., Novakovic, K., Hilkens, C. M. U. & Ferreira, A. M. Interplay between biomaterials and the immune system: challenges and opportunities in regenerative medicine. Acta Biomater. 155, 1\u201318 (2023).","journal-title":"Acta Biomater."},{"key":"1697_CR58","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1038\/s12276-023-01086-x","volume":"55","author":"Y Lee","year":"2023","unstructured":"Lee, Y., Jeong, M., Park, J., Jung, H. & Lee, H. Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics. Exp. Mol. Med. 55, 2085\u20132096 (2023).","journal-title":"Exp. Mol. Med."},{"key":"1697_CR59","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1039\/C6CS00636A","volume":"46","author":"S Behzadi","year":"2017","unstructured":"Behzadi, S. et al. Cellular uptake of nanoparticles: journey inside the cell. Chem. Soc. Rev. 46, 4218\u20134244 (2017).","journal-title":"Chem. Soc. Rev."},{"key":"1697_CR60","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/s41590-025-02212-9","volume":"26","author":"BN Lambrecht","year":"2025","unstructured":"Lambrecht, B. N., Ahmed, E. & Hammad, H. The immunology of asthma. Nat. Immunol. 26, 1233\u20131245 (2025).","journal-title":"Nat. Immunol."},{"key":"1697_CR61","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1111\/j.1582-4934.2011.01509.x","volume":"16","author":"S Schu","year":"2012","unstructured":"Schu, S. et al. Immunogenicity of allogeneic mesenchymal stem cells. J. Cell. Mol. Med. 16, 2094\u20132103 (2012).","journal-title":"J. Cell. Mol. Med."},{"key":"1697_CR62","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/j.1365-3083.2007.01905.x","volume":"65","author":"I Rasmusson","year":"2007","unstructured":"Rasmusson, I., Le Blanc, K., Sundberg, B. & Ringd\u00e9n, O. Mesenchymal stem cells stimulate antibody secretion in human B cells. Scand. J. Immunol. 65, 336\u2013343 (2007).","journal-title":"Scand. J. Immunol."},{"key":"1697_CR63","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1038\/s41587-022-01491-z","volume":"40","author":"E Rohner","year":"2022","unstructured":"Rohner, E., Yang, R., Foo, K. S., Goedel, A. & Chien, K. R. Unlocking the promise of mRNA therapeutics. Nat. Biotechnol. 40, 1586\u20131600 (2022).","journal-title":"Nat. Biotechnol."},{"key":"1697_CR64","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s13287-022-03043-3","volume":"13","author":"LV Lozano Navarro","year":"2022","unstructured":"Lozano Navarro, L. V. et al. Mesenchymal stem cells for critical limb ischemia: their function, mechanism, and therapeutic potential. Stem Cell Res. Ther. 13, 345 (2022).","journal-title":"Stem Cell Res. Ther."},{"key":"1697_CR65","doi-asserted-by":"publisher","first-page":"eaam7828","DOI":"10.1126\/scitranslmed.aam7828","volume":"9","author":"A Galleu","year":"2017","unstructured":"Galleu, A. et al. Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation. Sci. Transl. Med. 9, eaam7828 (2017).","journal-title":"Sci. Transl. Med."},{"key":"1697_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26834-3","volume":"12","author":"SHM Pang","year":"2021","unstructured":"Pang, S. H. M. et al. Mesenchymal stromal cell apoptosis is required for their therapeutic function. Nat. Commun. 12, 6495 (2021).","journal-title":"Nat. Commun."},{"key":"1697_CR67","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41419-021-03839-w","volume":"12","author":"MB Preda","year":"2021","unstructured":"Preda, M. B. et al. Short lifespan of syngeneic transplanted MSC is a consequence of in vivo apoptosis and immune cell recruitment in mice. Cell Death Dis. 12, 566 (2021).","journal-title":"Cell Death Dis."},{"key":"1697_CR68","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41536-024-00347-1","volume":"9","author":"M Dave","year":"2024","unstructured":"Dave, M. et al. MSCs mediate long-term efficacy in a Crohn\u2019s disease model by sustained anti-inflammatory macrophage programming via efferocytosis. npj Regen. Med. 9, 6 (2024).","journal-title":"npj Regen. Med."},{"key":"1697_CR69","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41419-020-02748-8","volume":"11","author":"N Karbian","year":"2020","unstructured":"Karbian, N. et al. Apoptotic cell therapy for cytokine storm associated with acute severe sepsis. Cell Death Dis. 11, 535 (2020).","journal-title":"Cell Death Dis."},{"key":"1697_CR70","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/stem.3165","volume":"38","author":"ARR Weiss","year":"2020","unstructured":"Weiss, A. R. R. et al. Differential effects of heat-inactivated, secretome-deficient MSC and metabolically active MSC in sepsis and allogenic heart transplantation. Stem Cells 38, 797\u2013807 (2020).","journal-title":"Stem Cells"},{"key":"1697_CR71","doi-asserted-by":"publisher","first-page":"e2212210","DOI":"10.1002\/adma.202212210","volume":"35","author":"Q Wu","year":"2023","unstructured":"Wu, Q. et al. Inhibition of tumor metastasis by liquid-nitrogen-shocked tumor cells with oncolytic viruses infection. Adv. Mater. 35, e2212210 (2023).","journal-title":"Adv. Mater."},{"key":"1697_CR72","doi-asserted-by":"publisher","first-page":"2310364","DOI":"10.1002\/adfm.202310364","volume":"34","author":"X Shi","year":"2024","unstructured":"Shi, X. et al. Combination of cryo-shocked M1 macrophages and lonidamine nanodrugs enables potent chemo-immunotherapy. Adv. Funct. Mater. 34, 2310364 (2024).","journal-title":"Adv. Funct. Mater."},{"key":"1697_CR73","doi-asserted-by":"publisher","first-page":"1359946","DOI":"10.3389\/fchem.2024.1359946","volume":"12","author":"Q Gao","year":"2024","unstructured":"Gao, Q. et al. Autologous cryo-shocked neutrophils enable targeted therapy of sepsis via broad-spectrum neutralization of pro-inflammatory cytokines and endotoxins. Front. Chem. 12, 1359946 (2024).","journal-title":"Front. Chem."},{"key":"1697_CR74","doi-asserted-by":"publisher","first-page":"6519","DOI":"10.1021\/acsnano.2c11865","volume":"17","author":"X Quan","year":"2023","unstructured":"Quan, X. et al. Cryo-shocked platelet coupled with ROS-responsive nanomedicine for targeted treatment of thromboembolic disease. ACS Nano 17, 6519\u20136533 (2023).","journal-title":"ACS Nano"},{"key":"1697_CR75","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41551-018-0227-9","volume":"2","author":"M Shin","year":"2018","unstructured":"Shin, M. et al. Targeting protein and peptide therapeutics to the heart via tannic acid modification. Nat. Biomed. Eng. 2, 304\u2013317 (2018).","journal-title":"Nat. Biomed. Eng."},{"key":"1697_CR76","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jconrel.2019.03.014","volume":"301","author":"Z He","year":"2019","unstructured":"He, Z. et al. Sustained release of exendin-4 from tannic acid\/Fe (III) nanoparticles prolongs blood glycemic control in a mouse model of type II diabetes. J. Control. Release 301, 119\u2013128 (2019).","journal-title":"J. Control. Release"},{"key":"1697_CR77","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/adfm.201403992","volume":"25","author":"M Shin","year":"2015","unstructured":"Shin, M. et al. DNA\/tannic acid hybrid gel exhibiting biodegradability, extensibility, tissue adhesiveness, and hemostatic ability. Adv. Funct. Mater. 25, 1270\u20131278 (2015).","journal-title":"Adv. Funct. Mater."},{"key":"1697_CR78","doi-asserted-by":"publisher","first-page":"123229","DOI":"10.1016\/j.ijpharm.2023.123229","volume":"643","author":"K Utatsu","year":"2023","unstructured":"Utatsu, K., Motoyama, K., Nakamura, T., Onodera, R. & Higashi, T. Tannic acid-based sustained-release system for protein drugs. Int. J. Pharm. 643, 123229 (2023).","journal-title":"Int. J. Pharm."},{"key":"1697_CR79","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/s41551-021-00815-9","volume":"6","author":"H Wang","year":"2022","unstructured":"Wang, H. et al. Genetically engineered and enucleated human mesenchymal stromal cells for the targeted delivery of therapeutics to diseased tissue. Nat. Biomed. Eng. 6, 882\u2013897 (2022).","journal-title":"Nat. Biomed. Eng."},{"key":"1697_CR80","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1016\/j.ijbiomac.2021.05.179","volume":"182","author":"JM Nascimento do","year":"2021","unstructured":"Nascimento do, J. M. et al. Evaluation of the influence of temperature on the protein\u2013tannic acid complex. Int. J. Biol. Macromol. 182, 2056\u20132065 (2021).","journal-title":"Int. J. Biol. Macromol."},{"key":"1697_CR81","doi-asserted-by":"publisher","first-page":"7689","DOI":"10.1039\/D1RA07657D","volume":"12","author":"C Chen","year":"2022","unstructured":"Chen, C., Yang, H., Yang, X. & Ma, Q. Tannic acid: a crosslinker leading to versatile functional polymeric networks: a review. RSC Adv. 12, 7689\u20137711 (2022).","journal-title":"RSC Adv."},{"key":"1697_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56736-7","volume":"16","author":"A Leduc","year":"2025","unstructured":"Leduc, A., Xu, Y., Shipkovenska, G., Dou, Z. & Slavov, N. Limiting the impact of protein leakage in single-cell proteomics. Nat. Commun. 16, 4169 (2025).","journal-title":"Nat. Commun."},{"key":"1697_CR83","doi-asserted-by":"publisher","first-page":"244","DOI":"10.2142\/biophysico.bppb-v18.027","volume":"18","author":"C-G Pack","year":"2021","unstructured":"Pack, C.-G. Application of quantitative cell imaging using label-free optical diffraction tomography. Biophys. Physicobiology 18, 244\u2013253 (2021).","journal-title":"Biophys. Physicobiology"},{"key":"1697_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-25286-z","volume":"12","author":"M Suzuki","year":"2022","unstructured":"Suzuki, M., Shindo, Y., Yamanaka, R. & Oka, K. Live imaging of apoptotic signaling flow using tunable combinatorial FRET-based bioprobes for cell population analysis of caspase cascades. Sci. Rep. 12, 21160 (2022).","journal-title":"Sci. Rep."},{"key":"1697_CR85","doi-asserted-by":"publisher","first-page":"096368972311801","DOI":"10.1177\/09636897231180128","volume":"32","author":"S Huang","year":"2023","unstructured":"Huang, S. et al. Mesenchymal stem\/stromal cells in asthma therapy: mechanisms and strategies for enhancement. Cell Transplant. 32, 09636897231180128 (2023).","journal-title":"Cell Transplant."},{"key":"1697_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-16165-8","volume":"12","author":"JY Choi","year":"2022","unstructured":"Choi, J. Y., Hur, J., Jeon, S., Jung, C. K. & Rhee, C. K. Effects of human adipose tissue- and bone marrow-derived mesenchymal stem cells on airway inflammation and remodeling in a murine model of chronic asthma. Sci. Rep. 12, 12032 (2022).","journal-title":"Sci. Rep."},{"key":"1697_CR87","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/jcbfm.2013.32","volume":"33","author":"M Janowski","year":"2013","unstructured":"Janowski, M. et al. Cell size and velocity of injection are major determinants of the safety of intracarotid stem cell transplantation. J. Cereb. Blood Flow Metab. 33, 921\u2013927 (2013).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"1697_CR88","doi-asserted-by":"publisher","first-page":"eabn8614","DOI":"10.1126\/sciadv.abn8614","volume":"8","author":"TT Nguyen","year":"2022","unstructured":"Nguyen, T. T. et al. Engineering of hybrid spheroids of mesenchymal stem cells and drug depots for immunomodulating effect in islet xenotransplantation. Sci. Adv. 8, eabn8614 (2022).","journal-title":"Sci. Adv."},{"key":"1697_CR89","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejpb.2022.01.007","volume":"172","author":"A Gonzalez-Pujana","year":"2022","unstructured":"Gonzalez-Pujana, A. et al. Mesenchymal stromal cells encapsulated in licensing hydrogels exert delocalized systemic protection against ulcerative colitis via subcutaneous xenotransplantation. Eur. J. Pharm. Biopharm. 172, 31\u201340 (2022).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"1697_CR90","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13287-020-01642-6","volume":"11","author":"N Ishiuchi","year":"2020","unstructured":"Ishiuchi, N. et al. Hypoxia-preconditioned mesenchymal stem cells prevent renal fibrosis and inflammation in ischemia-reperfusion rats. Stem Cell Res. Ther. 11, 130 (2020).","journal-title":"Stem Cell Res. Ther."},{"key":"1697_CR91","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1182\/blood-2005-05-1923","volume":"107","author":"JS Carew","year":"2006","unstructured":"Carew, J. S. et al. Targeting endoplasmic reticulum protein transport: a novel strategy to kill malignant B cells and overcome fludarabine resistance in CLL. Blood 107, 222\u2013231 (2006).","journal-title":"Blood"},{"key":"1697_CR92","doi-asserted-by":"publisher","first-page":"e89882","DOI":"10.1371\/journal.pone.0089882","volume":"9","author":"JS Elman","year":"2014","unstructured":"Elman, J. S. et al. Pharmacokinetics of natural and engineered secreted factors delivered by mesenchymal stromal cells. PLoS ONE 9, e89882 (2014).","journal-title":"PLoS ONE"},{"key":"1697_CR93","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nprot.2014.002","volume":"9","author":"JA Ankrum","year":"2014","unstructured":"Ankrum, J. A. et al. Engineering cells with intracellular agent-loaded microparticles to control cell phenotype. Nat. Protoc. 9, 233\u2013245 (2014).","journal-title":"Nat. Protoc."},{"key":"1697_CR94","doi-asserted-by":"publisher","first-page":"119415","DOI":"10.1016\/j.biomaterials.2019.119415","volume":"221","author":"TT Nguyen","year":"2019","unstructured":"Nguyen, T. T. et al. Engineering \u2018cell-particle hybrids\u2019 of pancreatic islets and bioadhesive FK506-loaded polymeric microspheres for local immunomodulation in xenogeneic islet transplantation. Biomaterials 221, 119415 (2019).","journal-title":"Biomaterials"},{"key":"1697_CR95","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrg3068","volume":"12","author":"JA Martin","year":"2011","unstructured":"Martin, J. A. & Wang, Z. Next-generation transcriptome assembly. Nat. Rev. Genet. 12, 671\u2013682 (2011).","journal-title":"Nat. Rev. Genet."},{"key":"1697_CR96","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13287-020-1584-3","volume":"11","author":"S Jin","year":"2020","unstructured":"Jin, S. et al. Conditioned medium derived from FGF-2-modified GMSCs enhances migration and angiogenesis of human umbilical vein endothelial cells. Stem Cell Res. Ther. 11, 68 (2020).","journal-title":"Stem Cell Res. Ther."},{"key":"1697_CR97","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/s42003-022-03838-3","volume":"5","author":"Y-J Kim","year":"2022","unstructured":"Kim, Y.-J. et al. Increasing angiogenic efficacy of conditioned medium using light stimulation of human adipose-derived stem cells. Commun. Biol. 5, 957 (2022).","journal-title":"Commun. Biol."},{"key":"1697_CR98","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13287-020-02074-y","volume":"12","author":"L Kong","year":"2021","unstructured":"Kong, L. et al. Conditioned media from endothelial progenitor cells cultured in simulated microgravity promote angiogenesis and bone fracture healing. Stem Cell Res. Ther. 12, 47 (2021).","journal-title":"Stem Cell Res. Ther."},{"key":"1697_CR99","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1039\/C9NR08670F","volume":"12","author":"A Ramesh","year":"2020","unstructured":"Ramesh, A., Kumar, S., Nguyen, A., Brouillard, A. & Kulkarni, A. Lipid-based phagocytosis nanoenhancer for macrophage immunotherapy. Nanoscale 12, 1875\u20131885 (2020).","journal-title":"Nanoscale"},{"key":"1697_CR100","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s13287-017-0744-6","volume":"8","author":"B Wang","year":"2017","unstructured":"Wang, B. et al. mTOR inhibition improves the immunomodulatory properties of human bone marrow mesenchymal stem cells by inducing COX-2 and PGE2. Stem Cell Res. Ther. 8, 292 (2017).","journal-title":"Stem Cell Res. Ther."},{"key":"1697_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14480-0","volume":"11","author":"JB Lee","year":"2020","unstructured":"Lee, J. B. et al. Microchannel network hydrogel induced ischemic blood perfusion connection. Nat. Commun. 11, 615 (2020).","journal-title":"Nat. Commun."},{"key":"1697_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-42520-3","volume":"9","author":"L Wang","year":"2019","unstructured":"Wang, L., Chen, Z., Li, Y., Yang, J. & Li, Y. Optical coherence tomography angiography for noninvasive evaluation of angiogenesis in a limb ischemia mouse model. Sci. Rep. 9, 5980 (2019).","journal-title":"Sci. Rep."}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01697-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01697-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01697-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T09:03:58Z","timestamp":1782723838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01697-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":102,"alternative-id":["1697"],"URL":"https:\/\/doi.org\/10.1038\/s41551-026-01697-5","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"16 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.-H.J., T.T.N., N.-N.N. and L.N. are submitting patent applications (Republic of Korea, 1020240127097; Japan, 2026-517888; China, 202480060308.7; USA, 19\/521,038; PCT\/KR2024\/014148) that include work in this paper. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}